The effects of cognitive-behavioral therapy components on cognitive mechanisms.
Aptose Biosciences secures funds for AML treatment development
Tuspetinib is being analysed for the treatment of acute myeloid leukaemia. Credit: Yomal2233/Shutterstock. Aptose Biosciences has secured a loan of $10m through a facility agreement